Neurotoxicity upon infusion of dimethylsulfoxide-cryopreserved peripheral blood stem cells in patients with and without pre-existing cerebral disease

European Journal of Haematology

Volumn 78, Issue 6, 2007, Pages 527-531

  Mueller, Lutz P ^a   Theurich, Sebastian ^a   Christopeit, Maximilian ^a   Grothe, Wilfried ^a   Muetherig, Anke ^a   Weber, Thomas ^a   Guenther, Susanne ^a   Behre, Gerhard ^a  

^a MARTIN LUTHER UNIVERSITY HALLE WITTENBERG   (Germany)

Author keywords

Dimethylsulfoxide; Neurotoxicity; Peripheral blood stem cells; Seizure

Indexed keywords

CARBOPLATIN; CARMUSTINE; CYCLOPHOSPHAMIDE; CYTARABINE; DIMETHYL SULFOXIDE; DIMETINDENE; ETOPOSIDE; FUROSEMIDE; GEMCITABINE; IFOSFAMIDE; MELPHALAN; PACLITAXEL; PREDNISOLONE; RANITIDINE; TREOSULFAN;

ADULT; AGED; ARTICLE; BRAIN DISEASE; CRYOPRESERVATION; DISEASE COURSE; DRUG MEGADOSE; FEMALE; GRAND MAL SEIZURE; HUMAN; LYMPHOMA; MAJOR CLINICAL STUDY; MALE; MULTIPLE MYELOMA; NEUROTOXICITY; PERIPHERAL BLOOD STEM CELL TRANSPLANTATION; PRIORITY JOURNAL; SEIZURE; SOLID TUMOR; TONIC CLONIC SEIZURE; WHOLE BODY RADIATION;

ADULT; AGED; BRAIN DISEASES; CRYOPRESERVATION; DIMETHYL SULFOXIDE; FEMALE; HUMANS; MALE; MIDDLE AGED; STEM CELL TRANSPLANTATION;

EID: 34248571913     PISSN: 09024441     EISSN: 16000609     Source Type: Journal    
DOI: 10.1111/j.1600-0609.2007.00851.x     Document Type: Article

References (22)

1. Frey NV, Lazarus HM, Goldstein SC. Has allogeneic stem cell cryopreservation been given the 'cold shoulder'? An analysis of the pros and cons of using frozen versus fresh stem cell products in allogeneic stem cell transplantation. Bone Marrow Transplant 2006 38 : 399 405.
2. Davis J, Rowley SD, Santos GW. Toxicity of autologous bone marrow graft infusion. Prog Clin Biol Res 1990 333 : 531 40.
3. Windrum P, Morris TC, Drake MB, Niederwieser D, Ruutu T. Variation in dimethyl sulfoxide use in stem cell transplantation: a survey of EBMT centres. Bone Marrow Transplant 2005 36 : 601 3.
4. Zambelli A, Poggi G, Da Prada G, Pedrazzoli P, Cuomo A, Miotti D, Perotti C, Preti P, Robustelli della Cuna G. Clinical toxicity of cryopreserved circulating progenitor cells infusion. Anticancer Res 1998 18 : 4705 8.
5. Ferrucci PF, Martinoni A, Cocorocchio E, et al. Evaluation of acute toxicities associated with autologous peripheral blood progenitor cell reinfusion in patients undergoing high-dose chemotherapy. Bone Marrow Transplant 2000 25 : 173 7.
6. Stroncek DF, Fautsch SK, Lasky LC, Hurd DD, Ramsay NK, McCullough J. Adverse reactions in patients transfused with cryopreserved marrow. Transfusion 1991 31 : 521 6.
7. Syme R, Bewick M, Stewart D, Porter K, Chadderton T, Gluck S. The role of depletion of dimethyl sulfoxide before autografting: on hematologic recovery, side effects, and toxicity. Biol Blood Marrow Transplant 2004 10 : 135 41.
8. Hoyt R, Szer J, Grigg A. Neurological events associated with the infusion of cryopreserved bone marrow and/or peripheral blood progenitor cells. Bone Marrow Transplant 2000 25 : 1285 7.
9. Hequet O, Dumontet C, El Jaafari-Corbin A, Salles G, Espinouse D, Arnaud P, Thieblemont C, Bouafia F, Coiffier B. Epileptic seizures after autologous peripheral blood progenitor infusion in a patient treated with high-dose chemotherapy for myeloma. Bone Marrow Transplant 2002 29 : 544.
10. Dhodapkar M, Goldberg SL, Tefferi A, Gertz MA. Reversible encephalopathy after cryopreserved peripheral blood stem cell infusion. Am J Hematol 1994 45 : 187 8.
11. Bauwens D, Hantson P, Laterre PF, Michaux L, Latinne D, De Tourtchaninoff M, Cosnard G, Hernalsteen D. Recurrent seizure and sustained encephalopathy associated with dimethylsulfoxide-preserved stem cell infusion. Leuk Lymphoma 2005 46 : 1671 4.
12. Higman MA, Port JD, Beauchamp NJ Jr., Chen AR. Reversible leukoencephalopathy associated with re-infusion of DMSO preserved stem cells. Bone Marrow Transplant 2000 26 : 797 800.
13. Windrum P, Morris TC. Severe neurotoxicity because of dimethyl sulphoxide following peripheral blood stem cell transplantation. Bone Marrow Transplant 2003 31 : 315.
14. Topacoglu H, Karcioglu O, Ozsarac M, Oray D, Niyazi Ozucelik D, Tuncok Y. Massive intracranial hemorrhage associated with the ingestion of dimethyl sulfoxide. Vet Hum Toxicol 2004 46 : 138 40.
15. Authier N, Dupuis E, Kwasiborski A, Eschalier A, Coudore F. Behavioural assessment of dimethylsulfoxide neurotoxicity in rats. Toxicol Lett 2002 132 : 117 21.
16. Cavaletti G, Oggioni N, Sala F, Pezzoni G, Cavalletti E, Marmiroli P, Petruccioli MG, Frattola L, Tredici G. Effect on the peripheral nervous system of systemically administered dimethylsulfoxide in the rat: a neurophysiological and pathological study. Toxicol Lett 2000 118 : 103 7.
17. Laroche V, McKenna DH, Moroff G, Schierman T, Kadidlo D, McCullough J. Cell loss and recovery in umbilical cord blood processing: a comparison of postthaw and postwash samples. Transfusion 2005 45 : 1909 16.
18. Scheinkonig C, Kappicht S, Kolb HJ, Schleuning M. Adoption of long-term cultures to evaluate the cryoprotective potential of trehalose for freezing hematopoietic stem cells. Bone Marrow Transplant 2004 34 : 531 6.
19. Neuwelt EA, Barnett P, Barranger J, McCormick C, Pagel M, Frenkel E. Inability of dimethyl sulfoxide and 5-fluorouracil to open the blood-brain barrier. Neurosurgery 1983 12 : 29 34.
20. Kaye TS, Egorin MJ, Riggs CE Jr., Olman EA, Chou FT, Salcman M. The plasma pharmacokinetics and tissue distribution of dimethyl sulfoxide in mice. Life Sci 1983 33 : 1223 30.
21. Wei EP, Kontos HA, Beckman JS. Antioxidants inhibit ATP-sensitive potassium channels in cerebral arterioles. Stroke 1998 29 : 817 22.
22. Schoerkhuber W, Kittler H, Sterz F, Behringer W, Holzer M, Frossard M, Spitzauer S, Laggner AN. Time course of serum neuron-specific enolase. A predictor of neurological outcome in patients resuscitated from cardiac arrest. Stroke 1999 30 : 1598 603.